Bacterial strains and growth conditions

MT Muralidhar Tata
MW Michael T. Wolfinger
FA Fabian Amman
NR Nicole Roschanski
AD Andreas Dötsch
ES Elisabeth Sonnleitner
SH Susanne Häussler
UB Udo Bläsi
request Request a Protocol
ask Ask a question
Favorite

The clinical isolate of Pseudomonas aeruginosa, PA14, was used in all experiments. The synthetic cystic fibrosis sputum medium was prepared a described by Palmer et al. [34] except that the concentration of FeSO4·7H2O was increased to 100 μM and that of KNO3 to 100 mM. This was done to allow for increased anaerobic biofilm formation after 96h, which was required for the extraction of sufficient amounts of RNA for subsequent RNASeq analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A